Ruxolitinib Combos Explored to Address MPN-Associated Symptoms
Published: Monday, May 06, 2019
Laura Michaelis, MD
One of the biggest challenges in patients with myeloproliferative neoplasms (MPNs) is managing associated symptoms, but a myriad of ongoing studies evaluating ruxolitinib (Jakafi) in combination are hoping to address this, said Laura Michaelis, MD.
... to read the full story